9999999997-17-008601.txt : 20170911
9999999997-17-008601.hdr.sgml : 20170911
20170911162208
ACCESSION NUMBER: 9999999997-17-008601
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20170911
DATE AS OF CHANGE: 20170911
ACTION DATE: 20170911
RECEIVED DATE: 20170911
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 171079210
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S
M=')E86T-96YD;V)J#7-T87)T>')E9@T*, T*)25%3T8-"B @(" @(" @#0HR
M,B P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X-"],(#8X+TQE;F=T
M:" V,B]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G (.2094P C$+ P<#%LP(# @-C$R(#7!E+T]B:E-T;3X^US[GX(?%0($)$ DP
M"2RP2P*!X, I""F!,V"417!U16Z/YBXURFB[OTL9GJ)P/QZ365T9&\LRCH=M
MS&Y#/.GE95-O4FU69'DS(YD^FO5X;.U?EO!#%:VVFSDPDDZZSW0.] /E)'LZ
MZ#XGJ0]>=VV/VL8IC]=.G:DR+Y[>97FI6UCHGW!?EZIZ[[2%*C5QBA5)F.
MIG6QG6=.3TVCS69/%G53JL*%'GQ)PE;TR:@BWTRJ7:&!DM3H\JO]GV/?'WJQ
MY"8_F+HAWP:MN$:GJM7H>2G];;6IMWFU(P]Y-:G:_/P]RYO67.]5 P&_R((/
MC8_T674.QB1)'[\;+"AK'K6K[%R>O7IK]NV*1Q1P1-2OPX%:$ 3@/>CXT_S=
M'8+S[A=G' N(&0,AI)N!3)P+XTD8>I^-H\>?BJ+8J?X>>EY/H\^+SM#>0;M?
M'^%"^D[L*FTGNYO1-K"'IE_580X^<@4O$Z$/_*8/@"@Y*_#<'7TL?I!7V<
M_0=]_<"WP/GO_/7TOA+P$& &A9B',-"F5N9'-TKK:4# R?X:L!&XC+((LJE]DOUL!VY T_3\
MUJ6>QU*UW0Z>!E_)_7*1S1PWI"F9PMIQ(YJ0S*&,C#/S=&8?@O-']F7@QC1)
MHDM,+[:8:J PU[/)_6J1+1Q<'2( C)=3P" !CT=D97$&&"MNU(P7.&*SY4?+'K1,C!&_ ]UABLV-XXO!%>J_)BF@:OTJ^
M)\2SA-RMIK,5W#CN"$E8C9?98GF#>2[G.@+S:1AB9?K=OMT=^6;W8CK#'>-?
M(%O-QMDM3OK,?!I'T>79_+X$*F+V>08]<4C9S!(%XTD&=W-@::#JX)/0 F)-
MWCLI8S1.WX0K3EGCNDG=?.]:^/60-X]YP3LIBKQLA["H"JHQ8AJP?XZ Q0V"
M5R=BIQ!,+YR+DL.RIL#<($E0Z?HP_KWWT'O1):'RB
M:+5R#,\&\"Z3BDY)189P<%P_B;P+ IP1#<@+%IR(1L10T7;;1U/\A++ %%^A
M!3TN/E0)"RGY#O(*\N.Q1!0IZ@JZ:H<2777(@Q]N7=]09Y#>S[+AWSK>2E$]
M0%%7>['CE11Y";+AN33YPXI3,(C&B/<*>-1'\,J#_,3
M$OB/HNQVF/J^J=5^]*4\<)C].(BMD"W(&G*8.PFI'3HBC5UB96TBO"<"M*SG
M_@9[E,(.,.*X>^A:"<%0&Y#2"H[J?2@"><@E?HG6\FRJ:T@PB-?;
M5JC;%OG6Y:78"]Y"WEZ6LZ@?'WE3J"$6<2^T*;!OQM&+-F-[7Y57>J%.0777
MF*AJ^.2EUE3MY@WGN]J\@WK?%\O GA+%=M5KAEF(<2&'$,$]7=,)A2CR-V2[
M<38DW#A#C3P5WT_:\FV*YYI]):U"P8A(^[%N#.A)S
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M-8G&$U5<_:*1*/?:(5'-E
M+##S+VH>8@>@9J[)C\A7!E+T]B:E-T;3X^R (L'Z+G9V $& (V%"#<-"F5N9'-T7!E+UA-3"]4>7!E+TUE=&%D
M871A/CYS=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP
M0V5H:4AZDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O
M8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N-BUC,#$U
M(#@T+C$U.3@Q,"P@,C Q-B\P.2\Q,"TP,CHT,3HS," @(" @(" @(CX*(" @
M/')D9CI21$8@>&UL;G,Z6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C&UL;G,Z>&UP/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN&UL;G,Z>&UP34T](FAT=' Z+R]N&%P+S$N
M,"]M;2\B/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/E!38W)I<'0U+F1L
M;"!697)S:6]N(#4N,BXR/"]X;7 Z0W)E871O&UP34TZ
M26YS=&%N8V5)1#YU=6ED.F)C,V$W-F0X+34W9F4M-&)F82UB.#!A+3$P,3-C
M-C S.3EA,3PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @/"]R9&8Z1&5S8W)I
M<'1I;VX^"B @(#POJ'5!:DZ@?,R]
M;L(P%$#A5[D;]D!B)X2?"B$!":A201%%L+"XM@N6W-SJ^H:^?C-T[GZ^LP %
MRV6^[OF!)-Z:2W/<-*?]6>9;\H8#=K5A+^J70NF96FBMIWI>SL=J,E)J]%<-
MLGVW%+ZYRER,&4!@E55F2%S _H_I^TA*ZWGL3:$GX8ACHD#C%Z CW+%-S$
M-70.?])-ROP<.'IQ"$.:\)/ABN1@#%ND9Y_:AZ$O8WW/P9J8RJJ<3.]D.MZ]
M'LD_Y6KU*\ 7QA*0PT*96YD7!E+UA2968O
M5ULQ(#(@,5T^/G-T')E9@T*,3$V#0HE)45/1@T*
end